QIAGEN MANCHESTER LIMITED (04160032) is a private limited company registered in MANCHESTER, incorporated in 2001. The company operates in the research and experimental development on biotechnology sector. With 103 data signals collected from 15 government and public sources, QIAGEN MANCHESTER LIMITED has one of the more comprehensive data profiles in our database. Risk assessment: 84/100 ("robust"), reflecting a strong compliance and financial profile.
QIAGEN MANCHESTER LIMITED (04160032) is an active private limited company incorporated in 2001, focusing on research and experimental development in biotechnology, located in Manchester.
Extensive data coverage from 15 government and public sources. Risk score of 84 indicates a strong compliance profile.
QIAGEN MANCHESTER LIMITED is 1 of 68 research and experimental development on biotechnology companies in MANCHESTER, out of 4,024 active companies in this sector nationally (4,909 including dissolved).
QIAGEN MANCHESTER LIMITED is listed as the proprietor of 1 property in the HM Land Registry.
Properties are located in North West.
QIAGEN MANCHESTER LIMITED has been awarded 1 government contract with a combined value of £38K.
The most recent contract was with THE UNIVERSITY OF BIRMINGHAM (17 Apr 2023).
2 employees as of 31 Dec 2025.
| Year | Turnover | Profit | Net Assets |
|---|---|---|---|
| 31 Dec 2025 | — | £11.8M | — |
| 31 Dec 2024 | — | £7.0M | — |
| 31 Dec 2023 | — | -£906K | — |
QIAGEN MANCHESTER LIMITED has received 1 Innovate UK grant.
QIAGEN MANCHESTER LIMITED pays invoices in an average of 32 days. 87% are paid within 30 days — a good payment track record.
This company profile is built from 12 official data sources: Ch Officers, Companies House, Contracts Finder, GLEIF, Gateway to Research, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, Innovate UK, Modern Slavery Registry, Payment Practices, Uk Trade Info.
QIAGEN MANCHESTER LIMITED (04160032) is an active private limited company incorporated in 2001, focusing on research and experimental development in biotechnology, located in Manchester..
Current directors include , MR PAUL JONATHAN BIRCH, .
QIAGEN MANCHESTER LIMITED is registered in MANCHESTER, United Kingdom.
QIAGEN MANCHESTER LIMITED operates under SIC code 72110 — Research and experimental development on biotechnology.
QIAGEN MANCHESTER LIMITED has a risk score of 84 out of 100, classified as "Robust". This score is calculated from 103 data signals across 15 government sources.
The next accounts for QIAGEN MANCHESTER LIMITED are due on 30 Sept 2027.
Yes, QIAGEN MANCHESTER LIMITED was previously known as DXS LIMITED.
Yes, QIAGEN MANCHESTER LIMITED is listed as the proprietor of 1 property in the HM Land Registry, located in North West.
Yes, QIAGEN MANCHESTER LIMITED has been awarded 1 government contract with a combined value of £38K.
According to the latest filed accounts (31 Dec 2025), QIAGEN MANCHESTER LIMITED has 3 employees.
The dissolution rate for the research and experimental development on biotechnology sector in the UK is 12.2%. The average company age in this sector is 7.2 years.
QIAGEN MANCHESTER LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
QIAGEN MANCHESTER LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
QIAGEN MANCHESTER LIMITED was incorporated on 14 Feb 2001, making it 25 years old. The company remains active and in good standing.
QIAGEN MANCHESTER LIMITED is classified under SIC code 72110 (Research and experimental development on biotechnology). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 103 data signals from 15 official government sources for QIAGEN MANCHESTER LIMITED.